-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
A large, international collaborative research analysis has identified, for the first time, the genetics of SARS-CoV-2 infection and disease severity in humans, identifying 13 new genomic regions associated with susceptibility and disease severity
The genetic makeup of an individual affects susceptibility to and response to viral infection, and while environmental, clinical, and social factors play a role in the severity of SARS-CoV-2 and COVID-19 disease, host genetics is also very important
Studies have shown that factors such as male gender, heavier weight, and older age can increase the severity of the disease in patients with new coronary pneumonia, but these risk factors alone cannot explain various changes in the severity of the disease
A genome-wide association meta-analysis of COVID-19 patients based on these studies identified novel loci associated with COVID-19 infection or COVID-19 severity
The researchers concluded that this international collaboration has identified novel host genetic factors associated with COVID-19 at unprecedented speed, and will continue to collect data to bring the size and diversity of lineages covered by the analysis to a new level
Editor-in-Chief
For more than a year, scientists and clinicians have been trying to understand why some people develop severe Covid-19 while others show few symptoms
